ALEXANDRIA, Va.–(BUSINESS WIRE)–Oxford Finance LLC (“Oxford” or the “Company”), a leading specialty finance firm, is pleased to announce the appointment of Nick McDearis to lead Asset-Based Lending (ABL) Originations. This … Continued
$800+ Million in New Capital Commitments 11 New Platform Transactions 6 New Sponsor Relationships 3 Credit Facility Upsizes 25 DDTL Fundings to Existing Borrowers SELECT RECENT TRANSACTIONS: June 2025: … Continued
ALEXANDRIA, Va.–(BUSINESS WIRE)–Oxford Finance LLC (“Oxford”), a leading specialty finance firm, is pleased to announce its Healthcare Real Estate and Asset-Based Lending (ABL) team closed 10 transactions with new loan … Continued
~$550 Million in New Capital Commitments 6 New Platform Transactions 3 New Sponsor Relationships 2 Credit Facility Upsizes 11 DDTL Fundings to Existing Borrowers SELECT TRANSACTIONS IN Q1-2025: March … Continued
ALEXANDRIA, Va.– (BUSINESS WIRE) –Oxford Finance LLC (“Oxford” or the “Company”) today announced its Board of Managers has appointed Timothy A. Lex as President and Chief Executive Officer. J. Alden … Continued
SAN DIEGO, Jan. 13, 2025 /PRNewswire/ — Inhibrx Biosciences, Inc. (“Inhibrx” or the “Company”) (Nasdaq: INBX), a biopharmaceutical company with two programs in ongoing clinical trials, today announced it entered into a … Continued
